Cargando…
Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for over 50 years. However, the molecular basis of its therapeutic role remained incompletely understood. Recent advances demonstrate that metformin could exert its glucose-lowering effect by multiple mechanism...
Autores principales: | Li, Min, Li, Xiaoying, Zhang, Huijie, Lu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079209/ https://www.ncbi.nlm.nih.gov/pubmed/30108523 http://dx.doi.org/10.3389/fphys.2018.01039 |
Ejemplares similares
-
Diabetes, pancreatic cancer, and metformin therapy
por: Gong, Jun, et al.
Publicado: (2014) -
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
por: Yang, Zhen, et al.
Publicado: (2020) -
Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling
por: Zhao, Jiejie, et al.
Publicado: (2018) -
Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy
por: Bai, Jing, et al.
Publicado: (2021) -
Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality
por: Tizazu, Anteneh Mehari, et al.
Publicado: (2019)